Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate.

Nieto K, Weghofer M, Sehr P, Ritter M, Sedlmeier S, Karanam B, Seitz H, M?ller M, Kellner M, H?rer M, Michaelis U, Roden RB, Gissmann L, Kleinschmidt JA. Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate. PLoS One. 2012; 7(6):e39741.

View in: PubMed

subject areas

Adjuvants, Immunologic
Animals
Enzyme-Linked Immunosorbent Assay
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Papillomaviridae
Rabbits
Viral Vaccines
Virion

authors with profiles

Balasubramanyam Karanam

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support